Clinical Trial Update: Comparison of Nephrotoxicity and Hospital Costs in Patients With Methicillin-Resistant Staphylococcus Aureus Bacteremia Who Received Vancomycin Versus Teicoplanin Therapy

View source ↗

Summary

This clinical trial update compares nephrotoxicity and hospital costs in patients with MRSA bacteremia treated with vancomycin versus teicoplanin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Bacteremia

Drugs mentioned

• Teicoplanin (Teicoplanin)
• Vancomycin (vancomycin)

Snippet

Sponsor: Taipei Medical University WanFang Hospital | Conditions: Staphylococcus Aureus, Bacteremia | Status: UNKNOWN